These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2076740)

  • 1. Laboratory screening method for selection of healthy volunteers.
    Sibille M; Vital Durand D
    Eur J Clin Pharmacol; 1990; 39(5):475-9. PubMed ID: 2076740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of healthy volunteers for phase I studies.
    Sibille M
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():167s-176s. PubMed ID: 2093628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bayesian approach to the design of phase II clinical trials.
    Sylvester RJ
    Biometrics; 1988 Sep; 44(3):823-36. PubMed ID: 3203131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials.
    Sibille M; Deigat N; Durieu I; Guillaumont M; Morel D; Bienvenu J; Massignon D; Durand DV
    Eur J Clin Pharmacol; 1999 Mar; 55(1):13-9. PubMed ID: 10206079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercurrent disease in healthy volunteers in pharmacological research.
    Sibille M; Vital Durand D; Levrat R
    Lancet; 1992 Apr; 339(8800):1058. PubMed ID: 1349084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
    Shao Y; Mukhi V; Goldberg JD
    Stat Med; 2008 Feb; 27(4):504-19. PubMed ID: 17854052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selection of healthy volunteers for clinical investigation: the case for volunteer pools.
    Joubert P; Pannall P
    Curr Med Res Opin; 1976; 4(3):192-6. PubMed ID: 780060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of laboratory tests using a programmable hand-held calculator: calculation of posterior probability and relative risk on the basis of prior probability and sensitivity, specificity and result of the test.
    van de Merwe JP
    Comput Biol Med; 1984; 14(1):107-11. PubMed ID: 6370577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bayesian methodology: an alternative to regular medical practice].
    Vírseda Chamorro M; Salinas Casado J; Hernández Lao A
    Arch Esp Urol; 2003 Nov; 56(9):977-82. PubMed ID: 14674281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.
    Clements MN; Corstjens PLAM; Binder S; Campbell CH; de Dood CJ; Fenwick A; Harrison W; Kayugi D; King CH; Kornelis D; Ndayishimiye O; Ortu G; Lamine MS; Zivieri A; Colley DG; van Dam GJ
    Parasit Vectors; 2018 Feb; 11(1):111. PubMed ID: 29475457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive factor--a method to simplify Bayes' formula and its application to diagnostic procedures.
    Köbberling J; Richter K; Tillil H
    Klin Wochenschr; 1984 Jun; 62(12):586-92. PubMed ID: 6332942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of clinical laboratory test results.
    Archer PG
    Am J Clin Pathol; 1978 Jan; 69(1):32-5. PubMed ID: 619612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two-step Fagan's nomogram: ad hoc interpretation of a diagnostic test result without calculation.
    Caraguel CG; Vanderstichel R
    Evid Based Med; 2013 Aug; 18(4):125-8. PubMed ID: 23468201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian evaluation of enrolling additional patients at the maximum tolerated dose in Phase I trials.
    Gönen M
    Contemp Clin Trials; 2005 Apr; 26(2):131-40. PubMed ID: 15837436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate, indeterminate, and uninterpretable diagnostic test results.
    Simel DL; Feussner JR; DeLong ER; Matchar DB
    Med Decis Making; 1987; 7(2):107-14. PubMed ID: 3574020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confidence limits of the probability of success in animal experiments and clinical studies: a Bayesian approach.
    Stavreva N; Stavrev P; Fallone GB
    Phys Med; 2009 Mar; 25(1):43-6. PubMed ID: 18280763
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.